Yahoo India Web Search

Search results

1. Top stories

   • The Economic Times

     Biocon Biologics mulls raising up to Rs 4,500 crore in bonds - The Economic Times

     Biocon Biologics Ltd. is considering raising Rs 4,000- 4,500 crore ($540 million) from India’s local-currency bond market in a few months, according to people familiar with ...

     16 hours ago

   • India Infoline

     Natural Biocon (India) Ltd Stock Price: Natural Biocon Share Price Today | India Infoline

     Natural Biocon (India) Ltd (NBL), was incorporated as a Public Limited Company on 27th August, 1992 and obtained a Certificate of Commencement of Business on 8th September ...

     20 hours ago

   • Livemint

     Nifty 50 July series: From Vedanta to Biocon—4 stocks where investors can park their money; Do you own? | Stock Market News

     6 days ago

   • CNBC Awaaz

     Buy Biocon; target of Rs 400: Sharekhan

     Sharekhan is bullish on Biocon has recommended buy rating on the stock with a target price of Rs 400 in its research report dated June 28, 2024.

     5 days ago

   • CNBC Awaaz

     Biocon - Meeting Conducted With Institutional Investors/ Research Analysts

     Biocon - Meeting Conducted With Institutional Investors/ Research Analysts

     5 days ago

   • 

     Financial Express

     Budget 2024 | Research-linked incentive scheme, need of the hour: Kiran Mazumdar-Shaw

     4 days ago

   View all

2. www.biocon.comBiocon - India's largest biopharmaceutical company

   www.biocon.com

   • Cached

   Jun 24, 2024 · Biocon is an innovation led fully integrated biopharmaceutical company that develop affordable biosimilars, generic formulations & complex APIs.

3. en.wikipedia.org › wiki › BioconBiocon - Wikipedia

   en.wikipedia.org › wiki › Biocon

   • Cached

   Biocon Limited is an Indian biopharmaceutical company based in Bangalore. It was founded by Kiran Mazumdar-Shaw in 1978. [4] The company manufactures generic active pharmaceutical ingredients (APIs) that are sold in approximately 120 countries, [5] including the United States and Europe. [4]

4. www.biocon.com › about-usAbout Us - Biocon Biopharmaceutical company India

   www.biocon.com › about-us

   • Cached

   A global biopharmaceutical company changing patients’ lives by finding new & affordable ways to treat diabetes, cancer & autoimmune diseases.

5. www.biocon.com › about-us › who-we-areWho we are - Biocon - Global Biopharmaceutical company

   www.biocon.com › about-us › who-we-are

   • Cached

   We are committed to providing everyone, everywhere, affordable access to a speciality portfolio of medicines. We are steadfastly investing in developing novel therapies for diabetes, oncology and immunology. We are strengthening our global reach and economies of scale.

6. www.nseindia.com › get-quotes › equityBiocon Limited Share Price Today, Stock Price, Live NSE News ...

   www.nseindia.com › get-quotes › equity

   • Cached

   2 days ago · Biocon Limited Stock Price Today, Live NSE Share Price: Get the latest Biocon Limited news, company updates, quotes, tips, historical charts, 52 week high low, market performance financial reports and many more at NSE India.

7. health.economictimes.indiatimes.com › news › pharmaBiocon mAns facility approved by EMA to manufacture cancer ...

   health.economictimes.indiatimes.com › news › pharma

   • Cached

   Jun 24, 2024 · Biocon announced that its Bengaluru mAbs facility has been approved by the European Medicines Agency (EMA) to manufacture biosimilar ‘Bevacizumab’. It is a type of targeted cancer drug treatment.

8. economictimes.indiatimes.com › biocon-ltd › stocksBiocon Share Price Today (04 Jul, 2024), Biocon Stock Price ...

   economictimes.indiatimes.com › biocon-ltd › stocks

   • Cached

   1 day ago · Biocon Share Price Today (04 Jul, 2024): Biocon Stock Price (₹ 363.75) Live NSE/BSE updates on The Economic Times. Check out why Biocon share price is up today. Get all details on Biocon shares news and analysis, Forecasts, Dividend, balance sheet, profit & loss, Quarterly results, annual report information, and more